its

Anniversary boost: Spielwarenmesse strengthens its global leadership

The industry platform with international appealA source of innovation and inspiration for the toy worldNUREMBERG, Germany, Feb. 2, 2026 /PRNewswire/…

1 month ago

MAYBELLINE NEW YORK WELCOMES KIARA ADVANI AS ITS BRAND AMBASSADOR, MARKING A NEW ERA OF BEAUTY IN INDIA

MUMBAI, India, Feb. 2, 2026 /PRNewswire/ -- Maybelline New York, the world's number one makeup brand, today introduced one of…

1 month ago

CGI appoints Gopal Chhetri to lead its Global Capability Centers business

BANGALORE, India, Jan. 30, 2026 /PRNewswire/ -- CGI (TSX: GIB.A) (NYSE: GIB), one of the world's largest independent IT and business…

1 month ago

IBM Elects Ramon L. Laguarta to its Board of Directors

ARMONK, N.Y., Jan. 30, 2026 /PRNewswire/ -- The IBM (NYSE: IBM) board of directors has elected Ramon L. Laguarta to…

1 month ago

Enfinity Global achieves Commercial Operation of First Project Under its 366 MW portfolio of PPAs with Microsoft

MILAN, Jan. 29, 2026 /PRNewswire/ -- Enfinity Global announced today the commercial operation of the first project under its portfolio…

1 month ago

FITUR 2026 reinforces its leadership as a driver of global tourism

The International Tourism Trade Fair has once again confirmed its role as a key driver of Madrid's economy, generating an…

1 month ago

Guidepoint India Announces Strategic Expansion of its Mumbai Office

MUMBAI, India, Jan. 27, 2026 /PRNewswire/ -- Guidepoint India today announced the strategic relocation and expansion of its Mumbai Office,…

1 month ago

NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 month ago

MagickHome Opens Its Largest Experience Hub in Bangalore; Inaugurated by Rukmini Vasanth

Designed as a live-in showcase, consumers can truly see, touch, and feel what their future home can beBANGALORE, India, Jan.…

1 month ago

Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural…

1 month ago